Tapewire

Nasdaq · USD

RGP

RESOURCES CONNECTION, INC.

Export transactions ↓
Tapewire entity
6553
SEC CIK
0001084765
Parsed reports
333

Last 12 months

Inside the activity.

4 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202540
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 03, 2017 Filed Jan 4, 2017 21:35 UTC GrantCommon Stock 5,141 $0.00 $0.00
Disclosure

SEC source: 0001367557-17-000002 · edgardoc.xml · nonDerivative · entry 1

Wargotz Michael H · CIK 0001367557 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,273

F1 · date: Non Employee Director Restricted Stock Award

Read SEC document
January 03, 2017 Filed Jan 4, 2017 21:34 UTC GrantCommon Stock 5,141 $0.00 $0.00
Disclosure

SEC source: 0001203117-17-000002 · edgardoc.xml · nonDerivative · entry 1

KISTINGER ROBERT F · CIK 0001203117 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,273

F1 · date: Non Employee Director Restricted Stock Award

Read SEC document
January 03, 2017 Filed Jan 4, 2017 21:32 UTC GrantCommon Stock 5,141 $0.00 $0.00
Disclosure

SEC source: 0001236364-17-000002 · edgardoc.xml · nonDerivative · entry 1

SYKES JOLENE · CIK 0001236364 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,273

F1 · date: Non Employee Director Restricted Stock Award

Read SEC document
January 03, 2017 Filed Jan 4, 2017 21:31 UTC GrantCommon Stock 5,141 $0.00 $0.00
Disclosure

SEC source: 0001462890-17-000002 · edgardoc.xml · nonDerivative · entry 1

Crawford Susan J · CIK 0001462890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,273

F1 · date: Non Employee Director Restricted Stock Award

Read SEC document
December 14, 2016 Filed Dec 14, 2016 21:43 UTC GiftCommon Stock 7,500 $0.00 $0.00
Disclosure

SEC source: 0001133824-16-000005 · edgardoc.xml · nonDerivative · entry 1

MURRAY DONALD B · CIK 0001133824 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Murray Fam Trust

Disclosed balance after: 880,304

F1 · kind: Gift to Orange County Community Foundation

Read SEC document
October 31, 2016 Filed Nov 2, 2016 15:16 UTC
Shih AnneDirector
OtherCommon Stock 785 $0.00 $0.00
Disclosure

SEC source: 0001415988-16-000008 · edgardoc.xml · nonDerivative · entry 2

Shih Anne · CIK 0001415988 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Joint w/Spouse

Disclosed balance after: 10,000

F1 · kind: Shares of stock transferred from joint account w/spouse to the following: 1,570 total shares transferred to her son (875 shares) and daughter-in-law (875 shares).

Read SEC document
October 31, 2016 Filed Nov 2, 2016 15:16 UTC
Shih AnneDirector
OtherCommon Stock 785 $0.00 $0.00
Disclosure

SEC source: 0001415988-16-000008 · edgardoc.xml · nonDerivative · entry 1

Shih Anne · CIK 0001415988 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Joint w/Spouse

Disclosed balance after: 10,785

F1 · kind: Shares of stock transferred from joint account w/spouse to the following: 1,570 total shares transferred to her son (875 shares) and daughter-in-law (875 shares).

Read SEC document
September 09, 2016 Filed Oct 6, 2016 22:09 UTC
Cherbak AnthonyCEO & President
GrantNon-Qualified Stock Option (right to buy) · Derivative 70,000 $0.00 Strike: $14.52 $0.00
Disclosure

SEC source: 0001332688-16-000014 · edgardoc.xml · derivative · entry 1

Cherbak Anthony · CIK 0001332688 · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2026-09-09

F1 · derivative.exercise_date: Options vest 25% a year from date of grant.

Read SEC document
September 09, 2016 Filed Oct 6, 2016 22:08 UTC
DUCHENE KATE WChief Legal Officer & EVP HR
GrantNon-Qualified Stock Option (right to buy) · Derivative 38,000 $0.00 Strike: $14.52 $0.00
Disclosure

SEC source: 0001218774-16-000006 · edgardoc.xml · derivative · entry 1

DUCHENE KATE W · CIK 0001218774 · Chief Legal Officer & EVP HR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,000

Underlying: Common Stock · 38,000 shares

Expires 2026-09-09

F1 · derivative.exercise_date: Options vest 25% a year from date of grant.

Read SEC document
September 09, 2016 Filed Oct 11, 2016 13:48 UTC
MUELLER HERBERT MCFO & EVP Corporate Dev.
GrantNon-Qualified Stock Option (right to buy) · Derivative 15,000 $0.00 Strike: $14.52 $0.00
Disclosure

SEC source: 0001249448-16-000006 · edgardoc.xml · derivative · entry 2

MUELLER HERBERT M · CIK 0001249448 · CFO & EVP Corporate Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2026-09-09

F1 · derivative.exercise_date: Award vests 25% after one year and 25% each year thereafter for the next three years.

Read SEC document
September 09, 2016 Filed Oct 11, 2016 13:48 UTC
MUELLER HERBERT MCFO & EVP Corporate Dev.
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001249448-16-000006 · edgardoc.xml · nonDerivative · entry 1

MUELLER HERBERT M · CIK 0001249448 · CFO & EVP Corporate Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,298

F1 · date: Award vests 25% after one year and 25% each year thereafter for the next three years.

Read SEC document
September 09, 2016 Filed Oct 13, 2016 22:21 UTC
BOWER JOHN DSr. VP of Finance
GrantNon-Qualified Stock Option (right to buy) · Derivative 15,000 $0.00 Strike: $14.52 $0.00
Disclosure

SEC source: 0001218772-16-000002 · edgardoc.xml · derivative · entry 1

BOWER JOHN D · CIK 0001218772 · Sr. VP of Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2026-09-09

F1 · derivative.exercise_date: Options vest 25% a year from date of grant.

Read SEC document
September 09, 2016 Filed Nov 4, 2016 20:18 UTC Amendment
Cherbak AnthonyCEO & President
GrantNon-Qualified Stock Option (right to buy) · Derivative 70,000 $0.00 Strike: $14.52 $0.00
Disclosure

SEC source: 0001510192-16-000148 · primary_doc.xml · derivative · entry 1

Cherbak Anthony · CIK 0001332688 · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2026-09-09

F1 · derivative.exercise_price: This amendment is filed to correct the Date of Earliest Transaction, Conversion or Exercise Price of Derivative Security, Transaction Date and Expiration Date as described below. On September 16, 2016, a Form 4 was filed for Anthony Cherbak reporting the grant of 70,000 Non-Qualified Stock Options on September 7, 2016. The date of the grant was actually September 9, 2016. On October 6, 2016, a second Form 4 was filed for Mr. Cherbak re-reporting the grant of 70,000 Non-Qualified Stock Options to reflect the correct grant date of September 9, 2016; however, this second Form 4 did not indicate that it was an amendment to the first Form 4 filed on September 16, 2016. (Please see footnote 2 for additional information.)

F2 · derivative.exercise_price: This amendment clarifies that (a) only one award of 70,000 Non-Qualified Stock Options was granted to Mr. Cherbak on September 9, 2016, with a Transaction Date of September 9, 2016 and an Expiration Date of September 9, 2026, (b) the correct exercise price is $14.52, and (c) that no other or additional grants of Non-Qualified Stock Options were made to Mr. Cherbak on September 7, 2016. Therefore the Form 4 filed for Mr. Cherbak on October 6, 2016 should be disregarded.

F1 · date: This amendment is filed to correct the Date of Earliest Transaction, Conversion or Exercise Price of Derivative Security, Transaction Date and Expiration Date as described below. On September 16, 2016, a Form 4 was filed for Anthony Cherbak reporting the grant of 70,000 Non-Qualified Stock Options on September 7, 2016. The date of the grant was actually September 9, 2016. On October 6, 2016, a second Form 4 was filed for Mr. Cherbak re-reporting the grant of 70,000 Non-Qualified Stock Options to reflect the correct grant date of September 9, 2016; however, this second Form 4 did not indicate that it was an amendment to the first Form 4 filed on September 16, 2016. (Please see footnote 2 for additional information.)

F2 · date: This amendment clarifies that (a) only one award of 70,000 Non-Qualified Stock Options was granted to Mr. Cherbak on September 9, 2016, with a Transaction Date of September 9, 2016 and an Expiration Date of September 9, 2026, (b) the correct exercise price is $14.52, and (c) that no other or additional grants of Non-Qualified Stock Options were made to Mr. Cherbak on September 7, 2016. Therefore the Form 4 filed for Mr. Cherbak on October 6, 2016 should be disregarded.

F3 · derivative.exercise_date: Options vest 25% a year from date of grant.

F1 · derivative.expiration_date: This amendment is filed to correct the Date of Earliest Transaction, Conversion or Exercise Price of Derivative Security, Transaction Date and Expiration Date as described below. On September 16, 2016, a Form 4 was filed for Anthony Cherbak reporting the grant of 70,000 Non-Qualified Stock Options on September 7, 2016. The date of the grant was actually September 9, 2016. On October 6, 2016, a second Form 4 was filed for Mr. Cherbak re-reporting the grant of 70,000 Non-Qualified Stock Options to reflect the correct grant date of September 9, 2016; however, this second Form 4 did not indicate that it was an amendment to the first Form 4 filed on September 16, 2016. (Please see footnote 2 for additional information.)

F2 · derivative.expiration_date: This amendment clarifies that (a) only one award of 70,000 Non-Qualified Stock Options was granted to Mr. Cherbak on September 9, 2016, with a Transaction Date of September 9, 2016 and an Expiration Date of September 9, 2026, (b) the correct exercise price is $14.52, and (c) that no other or additional grants of Non-Qualified Stock Options were made to Mr. Cherbak on September 7, 2016. Therefore the Form 4 filed for Mr. Cherbak on October 6, 2016 should be disregarded.

Read SEC document
September 09, 2016 Filed Nov 4, 2016 20:11 UTC Amendment
DUCHENE KATE WChief Legal Officer & EVP HR
GrantNon-Qualified Stock Option (right to buy) · Derivative 38,000 $0.00 Strike: $14.52 $0.00
Disclosure

SEC source: 0001510192-16-000147 · primary_doc.xml · derivative · entry 1

DUCHENE KATE W · CIK 0001218774 · Chief Legal Officer & EVP HR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,000

Underlying: Common Stock · 38,000 shares

Expires 2026-09-09

F1 · derivative.exercise_price: This amendment is filed to correct the Date of Earliest Transaction, Conversion or Exercise Price of Derivative Security, Transaction Date and Expiration Date as described below. On September 16, 2016, a Form 4 was filed for Kate W. Duchene reporting the grant of 38,000 Non-Qualified Stock Options on September 7, 2016. The date of the grant was actually September 9, 2016. On October 6, 2016, a second Form 4 was filed for Ms. Duchene re-reporting the grant of 38,000 Non-Qualified Stock Options to reflect the correct grant date of September 9, 2016; however, this second Form 4 did not indicate that it was an amendment to the first Form 4 filed on September 16, 2016. (Please see footnote 2 for additional information.)

F2 · derivative.exercise_price: This amendment clarifies that (a) only one award of 38,000 Non-Qualified Stock Options was granted to Ms. Duchene on September 9, 2016. with a Transaction Date of September 9, 2016 and an Expiration Date of September 9, 2026, (b) the correct exercise price is $14.52, and (c) that no other or additional grants of Non-Qualified Stock Options were made to Ms. Duchene on September 7, 2016. Therefore the Form 4 filed for Ms. Duchene on October 6, 2016 should be disregarded.

F1 · date: This amendment is filed to correct the Date of Earliest Transaction, Conversion or Exercise Price of Derivative Security, Transaction Date and Expiration Date as described below. On September 16, 2016, a Form 4 was filed for Kate W. Duchene reporting the grant of 38,000 Non-Qualified Stock Options on September 7, 2016. The date of the grant was actually September 9, 2016. On October 6, 2016, a second Form 4 was filed for Ms. Duchene re-reporting the grant of 38,000 Non-Qualified Stock Options to reflect the correct grant date of September 9, 2016; however, this second Form 4 did not indicate that it was an amendment to the first Form 4 filed on September 16, 2016. (Please see footnote 2 for additional information.)

F2 · date: This amendment clarifies that (a) only one award of 38,000 Non-Qualified Stock Options was granted to Ms. Duchene on September 9, 2016. with a Transaction Date of September 9, 2016 and an Expiration Date of September 9, 2026, (b) the correct exercise price is $14.52, and (c) that no other or additional grants of Non-Qualified Stock Options were made to Ms. Duchene on September 7, 2016. Therefore the Form 4 filed for Ms. Duchene on October 6, 2016 should be disregarded.

F3 · derivative.exercise_date: Options vest 25% a year from date of grant.

F1 · derivative.expiration_date: This amendment is filed to correct the Date of Earliest Transaction, Conversion or Exercise Price of Derivative Security, Transaction Date and Expiration Date as described below. On September 16, 2016, a Form 4 was filed for Kate W. Duchene reporting the grant of 38,000 Non-Qualified Stock Options on September 7, 2016. The date of the grant was actually September 9, 2016. On October 6, 2016, a second Form 4 was filed for Ms. Duchene re-reporting the grant of 38,000 Non-Qualified Stock Options to reflect the correct grant date of September 9, 2016; however, this second Form 4 did not indicate that it was an amendment to the first Form 4 filed on September 16, 2016. (Please see footnote 2 for additional information.)

F2 · derivative.expiration_date: This amendment clarifies that (a) only one award of 38,000 Non-Qualified Stock Options was granted to Ms. Duchene on September 9, 2016. with a Transaction Date of September 9, 2016 and an Expiration Date of September 9, 2026, (b) the correct exercise price is $14.52, and (c) that no other or additional grants of Non-Qualified Stock Options were made to Ms. Duchene on September 7, 2016. Therefore the Form 4 filed for Ms. Duchene on October 6, 2016 should be disregarded.

Read SEC document
September 07, 2016 Filed Sep 16, 2016 22:49 UTC
Cherbak AnthonyCEO & President
GrantNon-Qualified Stock Option (right to buy) · Derivative 70,000 $0.00 Strike: $15.10 $0.00
Disclosure

SEC source: 0001332688-16-000011 · edgardoc.xml · derivative · entry 1

Cherbak Anthony · CIK 0001332688 · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2026-09-07

F1 · derivative.exercise_date: Options vest 25% a year from date of grant.

Read SEC document
September 07, 2016 Filed Sep 16, 2016 22:48 UTC
DUCHENE KATE WChief Legal Officer & EVP HR
GrantNon-Qualified Stock Option (right to buy) · Derivative 38,000 $0.00 Strike: $15.10 $0.00
Disclosure

SEC source: 0001218774-16-000004 · edgardoc.xml · derivative · entry 1

DUCHENE KATE W · CIK 0001218774 · Chief Legal Officer & EVP HR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,000

Underlying: Common Stock · 38,000 shares

Expires 2026-09-07

F1 · derivative.exercise_date: Options vest 25% a year from date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.